Literature DB >> 26622864

Screening of potential biomarkers for chemoresistant ovarian carcinoma with miRNA expression profiling data by bioinformatics approach.

Shiyang Wei1, Yafeng Wang2, Hong Xu1, Yan Kuang1.   

Abstract

The aim of the present study was to screen out the biomarkers associated with chemoresistance in ovarian carcinomas and to investigate the molecular mechanisms. microRNA (miRNA) expression data was obtained from published microarray data of the GSE43867 dataset from Gene Expression Omnibus (GEO), including the data of 86 chemotherapy-treated patients with serous epithelial ovarian carcinomas (response group, 36 complete response cases and 12 partial response cases; non-response group, 10 stable cases and 28 progressive disease cases), and identification of differentially-expressed miRNAs were conducted with a GEO2R online tool based on R language. TargetScan 6.2 was used to predict the targets of differentially-expressed miRNAs. Protein-protein interaction network analysis was conducted by STRING 9.1, while functional enrichment [Gene Ontology (GO) biological process terms] and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were conducted by GeneCodis3 for the target genes. A total of 6 differentially-expressed miRNAs were screened out, with 317 target genes obtained. It was found that 67 interactions existed among 76 genes/proteins through the PPI network analysis, and that 6 of these were potential key genes (PIK3R5, MAPK3, PTEN, S1PR3, BDKRB2 and NCBP2). The main biological processes involved in chemoresistant ovarian carcinoma were apoptosis, programmed cell death, cell migration, cell death and cell motility. The miRNA target genes were found to be associated with the ErbB signaling pathway, the gonadotropin-releasing hormone signaling pathway and other pathways in cancer. IK3R5, MAPK3 and PIK3R5 are involved in the majority of GO terms and KEGG pathways associated with chemoresistance in ovarian carcinoma.

Entities:  

Keywords:  chemoresistance; enrichment analysis; microRNA; ovarian carcinomas; protein-protein interaction network

Year:  2015        PMID: 26622864      PMCID: PMC4580032          DOI: 10.3892/ol.2015.3610

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  39 in total

1.  Involvement of microRNA-198 overexpression in the poor prognosis of esophageal cancer.

Authors:  Bo Qi; Wen-Jian Yao; Bao-Sheng Zhao; Xiu-Guang Qin; Yi Wang; Wen-Ju Wang; Tian-Yun Wang; Shang-Guo Liu; Han-Chen Li
Journal:  Asian Pac J Cancer Prev       Date:  2013

2.  Analysis of long non-coding RNA expression profiles in gastric cancer.

Authors:  Wei-Jun Cao; Hai-Lu Wu; Bang-Shun He; Yu-Shu Zhang; Zhen-Yu Zhang
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

3.  Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer.

Authors:  Mohammed Tanjimur Rahman; Kentaro Nakayama; Munmun Rahman; Hiroshi Katagiri; Atsuko Katagiri; Tomoka Ishibashi; Masako Ishikawa; Kouji Iida; Satoru Nakayama; Yoshiro Otsuki; Kohji Miyazaki
Journal:  Am J Clin Pathol       Date:  2012-10       Impact factor: 2.493

4.  MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1.

Authors:  Li Wang; Ming Shi; Shuangxing Hou; Bojun Ding; Lijuan Liu; Xituan Ji; Jian Zhang; Yanchun Deng
Journal:  FEBS Lett       Date:  2012-03-27       Impact factor: 4.124

5.  Role of extracellular signal-regulated kinase (ERK)1/2 in multicellular resistance to docetaxel in MCF-7 cells.

Authors:  Eui Kyong Jeong; Su Yeon Lee; Hyun Min Jeon; Min Kyung Ju; Cho Hee Kim; Ho Sung Kang
Journal:  Int J Oncol       Date:  2010-09       Impact factor: 5.650

6.  MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells.

Authors:  Jean-Philippe Guégan; Frédéric Ezan; Nathalie Théret; Sophie Langouët; Georges Baffet
Journal:  Carcinogenesis       Date:  2012-10-05       Impact factor: 4.944

7.  Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs.

Authors:  David M Garcia; Daehyun Baek; Chanseok Shin; George W Bell; Andrew Grimson; David P Bartel
Journal:  Nat Struct Mol Biol       Date:  2011-09-11       Impact factor: 15.369

8.  Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer.

Authors:  J H Huh; T H Kim; K Kim; J-A Song; Y J Jung; J-Y Jeong; M J Lee; Y K Kim; D H Lee; H J An
Journal:  Br J Cancer       Date:  2013-06-27       Impact factor: 7.640

9.  GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information.

Authors:  Ruben Nogales-Cadenas; Pedro Carmona-Saez; Miguel Vazquez; Cesar Vicente; Xiaoyuan Yang; Francisco Tirado; Jose María Carazo; Alberto Pascual-Montano
Journal:  Nucleic Acids Res       Date:  2009-05-22       Impact factor: 16.971

10.  miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer.

Authors:  Iver Nordentoft; Karin Birkenkamp-Demtroder; Mads Agerbæk; Dan Theodorescu; Marie Stampe Ostenfeld; Arndt Hartmann; Michael Borre; Torben F Ørntoft; Lars Dyrskjøt
Journal:  BMC Med Genomics       Date:  2012-09-06       Impact factor: 3.063

View more
  6 in total

1.  m7G Methylation-Related Genes as Biomarkers for Predicting Overall Survival Outcomes for Hepatocellular Carcinoma.

Authors:  Xin-Yu Li; Zhi-Jie Zhao; Jing-Bing Wang; Yu-Hao Shao; Jian-Xiong You; Xi-Tao Yang
Journal:  Front Bioeng Biotechnol       Date:  2022-05-10

2.  Integrated bioinformatics analysis for the identification of potential key genes affecting the pathogenesis of clear cell renal cell carcinoma.

Authors:  Hao Cui; Lei Xu; Zhi Li; Ke-Zuo Hou; Xiao-Fang Che; Bo-Fang Liu; Yun-Peng Liu; Xiu-Juan Qu
Journal:  Oncol Lett       Date:  2020-06-05       Impact factor: 2.967

3.  The pattern of expression and prognostic value of key regulators for m7G RNA methylation in hepatocellular carcinoma.

Authors:  Jianxing Chen; Shibin Yao; Zhijuan Sun; Yanjun Wang; Jili Yue; Yongkang Cui; Chengping Yu; Haozhi Xu; Linqiang Li
Journal:  Front Genet       Date:  2022-09-02       Impact factor: 4.772

4.  FGMD: A novel approach for functional gene module detection in cancer.

Authors:  Daeyong Jin; Hyunju Lee
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

5.  A meta-analysis and bioinformatics exploration of the diagnostic value and molecular mechanism of miR-193a-5p in lung cancer.

Authors:  Zu-Cheng Xie; Rui-Xue Tang; Xiang Gao; Qiong-Ni Xie; Jia-Ying Lin; Gang Chen; Zu-Yun Li
Journal:  Oncol Lett       Date:  2018-07-19       Impact factor: 2.967

6.  Tumor-suppressor miRNA-27b-5p regulates the growth and metastatic behaviors of ovarian carcinoma cells by targeting CXCL1.

Authors:  Chun Hua Liu; Xue Ning Jing; Xiao Lan Liu; Shan Yong Qin; Min Wei Liu; Chun Hong Hou
Journal:  J Ovarian Res       Date:  2020-08-11       Impact factor: 4.234

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.